Alveron Pharma
PrivateLast Round
Seed
Dec 6, 2024
Total Funding Raised
$17.08M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Alveron Pharma is a biotechnology company developing a unique coagulation platform technology with the world's first cyclodextrin-based anticoagulant reversal drug.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alveron Pharma Comparables
Compare Alveron Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pinwheel Therapeutics | 90% | |
| VarmX | 89% | |
| Bioxodes | 82% |
Alveron Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 6, 2024 | ||||
| Debt | Oct 7, 2021 | ||||
| Series A Extension | Oct 7, 2021 | ||||
| Series A | May 16, 2019 |
Alveron Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Waterman Ventures | Seed, Series A, Series A Extension |
| Thuja Capital | Seed, Series A Extension, Series A |
| Waterman Ventures | Seed, Series A |
| Oost NL | Seed, Series A, Series A Extension |
| East Netherlands Development Agency (Oost NL) | Seed, Series A |
| Broadview Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 33% MoM, reaching 2.2K.
- May 18, 2026
Monthly visitors grew 104% MoM, reaching 1.2K.
Alveron Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Alveron Pharma's valuation, stock price, and market status.
Is Alveron Pharma a public or private company?
Alveron Pharma is a private company.
What is the current stock price of Alveron Pharma?
Alveron Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Alveron Pharma worth (valuation)?
Valuation information for Alveron Pharma is not publicly available.
Can I buy Alveron Pharma stock?
Alveron Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Alveron Pharma's last funding round?
Alveron Pharma's most recent funding round was Seed on December 6, 2024.
Who are the main investors in Alveron Pharma?
Key investors in Alveron Pharma include Thuja Capital, Broadview Ventures.
Will Alveron Pharma IPO soon?
No public IPO plans have been announced for Alveron Pharma.
How can I track Alveron Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alveron Pharma's secondary market activity and sign up for updates.